Valence ロゴ
人気
ログイン
Loading data for EMBC — first visit, this takes a few seconds.

ウォッチリストに追加

Embecta Corp.

NasdaqGS: EMBC · リアルタイム株価 · USD
5.42
+0.32 (6.27%)
終値時点： Aug 19, 2026, 3:59 PM

Embecta Corp. (EMBC) Stock Price, Analysis & Data

6.27%
買気配3.86
時価総額307.1M
売上高（TTM）1.02B
純利益（TTM）87.5M
ベータ0.79
EPS（TTM）1.56
PER（TTM）3.47
予想PER3.08
PBR（TTM）-0.50
PSR（TTM）0.30
Earnings DateNov 25, 2026
売気配6.63
出来高1,256,820
平均出来高（20日）1,923,956
始値5.10
前日終値5.10
当日レンジ5.10 - 5.43
52週レンジ2.77 - 15.55
アナリストn/a
目標株価n/a
配当$0.04 (0.78%)
権利落ち日2026年8月27日

EMBCについて

Embecta Corp., a medical device company, provides solutions to improve the health and wellbeing of people living with diabetes in the United States and internationally. The company's products include pen needles, syringes, and safety injection devices, as well as digital applications to assist people with managing patient's diabetes. It primarily sells its products to wholesalers and distributors. The company was formerly known as Berra Newco, In...

[続きを読む]
業種 Medical Instruments & Supplies
セクター Healthcare
IPO日 Mar 22, 2022
従業員数 1,850
上場取引所 NasdaqGS
ティッカー EMBC
ウェブサイト https://www.embecta.com
企業情報の全文

業績

2025年のEmbectaの売上高は1.08Bで、前年の1.12Bから-3.8%の減少でした。 利益は95.4Mで、21.84%の増加でした。

財務諸表

決算サプライズ

EmbectaはAug 7, 2026に四半期決算を発表しました：
  • 売上高は $271.7M で、予想を下回りました $0, うち -8.05% の前年比減少.
  • EPSは 0.56 で、予想を上回りました 0.29, うち -50.00% の前年比減少.

    • 次回決算発表

    Embecta Corp.の決算発表予定日は Nov 25, 2026, 寄り付き前の予定です。
    アナリストの売上高予想は ... アップグレード
    news image

    6日前 · Motley Fool

    Embecta (EMBC) Q3 2026 Earnings Call Transcript

    Revenue fell 8.1% year-over-year, but margin guidance rose for fiscal 2026.

    news image

    1週間前 · Moby

    Embecta Corp. Q3 2026 Earnings Call Summary

    Moby summary of Embecta Corp.'s Q3 2026 earnings call

    news image

    1週間前 · GuruFocus.com

    Embecta Corp (EMBC) (Q3 2026) Earnings Call Highlights: Strong Sequential Recovery and Raised ...

    Embecta Corp (EMBC) beats expectations with a $50 million sequential revenue jump, raises adjusted EPS guidance, and advances its Owen Mumford integration despite persistent U.S. market pressures.

    news image

    1週間前 · MarketBeat

    Embecta Q3 Earnings Call Highlights

    Embecta (NASDAQ:EMBC) reported fiscal third-quarter 2026 revenue of approximately $272 million, down 8.1% from the prior-year period on a reported basis and down 8.9% on an adjusted constant-currency ...

    news image

    1か月前 · Simply Wall St.

    Embecta (EMBC) Stock Fair Value Moves Lower As Analysts Reset Medtech Expectations

    Embecta is in focus after one fair value estimate was reset from US$15.00 to US$4.00, which highlights how much some analysts have reworked their view of what the stock might be worth under updated as...

    2ページ中1ページ